Is Nature Genetics Indexed in PubMed? Yes, With Active MEDLINE Coverage
Nature Genetics is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage beginning from volume 1, issue 1 in April 1992.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Nature Genetics at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 29.0 puts Nature Genetics in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~<10% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Nature Genetics takes ~~30 days. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs ~$11,690 USD. Check institutional agreements before submitting.
Quick answer: yes.
Nature Genetics is indexed in PubMed, currently indexed for MEDLINE, and searchable from volume 1, issue 1 in April 1992. That matters because genetics papers often need to cross from basic discovery into medical genetics, disease biology, and variant interpretation workflows.
PubMed coverage is part of how those papers travel beyond one genomics subfield after publication.
Direct answer
If you publish in Nature Genetics, the paper is discoverable in PubMed and the journal remains actively indexed for MEDLINE.
NLM field | What the record shows | Why it matters |
|---|---|---|
publication start year | 1992 | the title has long-running continuity under the current name |
PubMed coverage | v1n1, Apr. 1992- | searchable coverage starts from the first issue |
MEDLINE coverage | v1n1, Apr. 1992- | the journal sits inside the curated NLM journal index |
current indexing status | Currently indexed for MEDLINE | this is active coverage, not archival residue |
current subset | Index Medicus | the title sits inside the core biomedical indexing flow |
subject cue in the NLM record | Genetics, Medical | the record itself reflects medically adjacent discoverability |
That is the operational answer. The journal is visible in PubMed, active in MEDLINE, and searchable continuously from launch.
Why this matters for Nature Genetics
Strong Nature Genetics papers often need to reach more than one research culture at once:
- human and medical geneticists
- statistical and functional genomics readers
- disease researchers
- clinician-scientists following variant and mechanism interpretation
- translational teams using genetics results to prioritize targets or cohorts
Those readers often search by gene, syndrome, trait architecture, pathway, sequencing modality, or disease mechanism rather than by browsing one journal issue. PubMed indexing matters because it helps a genetics paper move across those adjacent research cultures naturally.
For this journal, discoverability is not a side issue. A high-end genetics paper often wins because it becomes legible both to core genomics readers and to medically oriented readers outside the immediate subfield. PubMed is one of the infrastructures that makes that possible.
What the indexing record tells you in practice
Practical question | What the record tells you |
|---|---|
will published papers surface in normal biomedical search behavior? | yes |
is the journal actively indexed for MEDLINE rather than merely appearing through an alternate route? | yes |
does searchable coverage begin from launch? | yes |
does indexing prove the paper is broad enough for Nature Genetics? | no |
does indexing tell you whether the story belongs in a disease journal or in a more methods-heavy genomics venue instead? | no |
That last point matters because the database answer is easier than the editorial answer.
PubMed versus MEDLINE for Nature Genetics
- PubMed means the paper is discoverable in the biomedical database most disease and genetics readers already use.
- MEDLINE means the journal remains inside the curated NLM journal index.
- Index Medicus reinforces that the title sits in the standard biomedical indexing structure rather than at the edge of it.
That combination matters because Nature Genetics papers frequently need to be found by readers who are not habitual genetics-journal browsers. Clinical geneticists, cancer researchers, neurologists, and rare-disease teams still start with PubMed.
How this compares with nearby journals
Journal pattern | What the indexing record usually supports | What it does not solve |
|---|---|---|
Nature Genetics | broad genetics plus medically adjacent discoverability | whether the result is field-shaping enough |
Genome Biology | strong genomics visibility | whether the paper has the same flagship genetics breadth |
disease-specific genetics venues | good discovery within one disease or method lane | cross-field flagship reach |
clinical specialty journals | strong disease readership | whether the paper still reads like a genetics-first story |
This is the useful submission implication. Indexing is usually not the limiting factor for Nature Genetics. Breadth, biological consequence, and general genetics interest are the limiting factors.
How to verify the indexing record yourself
If you want to check this directly, the process is short:
- open the NLM Catalog record
- confirm the PubMed and MEDLINE coverage lines
- confirm Current Indexing Status
- confirm the Current Subset line
- run a direct journal search in PubMed
- compare the latest results with the official journal site
That manual check is worth doing here because it shows the discoverability answer is straightforward: the title has continuous searchable coverage from its first issue and remains actively indexed.
What we see in PubMed-Indexing Questions for Nature Genetics
For PubMed-indexing questions for Nature Genetics, three patterns recur.
The genomics-versus-medicine confusion. Authors sometimes assume genetics papers are discoverable only within genomics circles. For this journal, that is usually too narrow. The indexing record supports broader biomedical visibility than that.
The indexing-as-validation shortcut. We also see authors treat active MEDLINE indexing as if it validates the journal choice. It does not. A visible paper can still be a bad fit if the biological consequence is too narrow or the story is too methods-heavy.
The wrong comparator set. Another frequent mistake is comparing Nature Genetics only to other genetics titles. The real choice is often between Nature Genetics, a disease flagship, and a genomics or methods journal. Indexing does not solve that decision. Editorial breadth does.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether the manuscript is broad enough or important enough for Nature Genetics.
Indexing tells you:
- the paper will be visible in standard biomedical search
- the title is actively indexed for MEDLINE
- searchable coverage starts from the journal's first issue
Indexing does not tell you:
- whether the work has enough biological consequence
- whether the study is broad enough for a flagship genetics audience
- whether the paper is better suited to a disease journal, a genomics journal, or a narrower specialty venue
That is why the better next reads are:
If the fit question is what you actually need answered, a Nature Genetics submission readiness check gives you a manuscript-specific signal before you submit.
What the NLM record means in practice for authors
The useful part of the Nature Genetics record is not simply that the journal appears in PubMed. It is that the discoverability story is clean and continuous from launch. The title starts in 1992, and the searchable PubMed and MEDLINE coverage begins there as well.
That matters because genetics papers often move into adjacent fields after publication. A paper may start as a discovery-genetics story and then become relevant to neurology, oncology, rare disease, or clinical variant interpretation. The PubMed and MEDLINE combination supports that travel across fields.
The NLM subject cues matter too. The record points toward medical genetics rather than a purely technical genomics label. That fits how the journal behaves in practice. The strongest papers here are not just data-rich. They usually matter to disease thinking, trait biology, or variant interpretation.
So the indexing answer is strong. But it is still only a discoverability answer. When authors ask whether the paper belongs in Nature Genetics, the real question is usually breadth, consequence, and generality. The database record does not settle that.
Submit If / Think Twice If
Use this indexing answer as enough reassurance if:
- your main concern is whether a published paper will be visible to genetics and medically adjacent readers
- you want confirmation that the journal remains actively indexed for MEDLINE
- you need a clean citation showing searchable coverage from launch
Think twice if:
- you are using PubMed inclusion as a shortcut for flagship fit
- the manuscript may be too narrow, too technical, or too disease-specific for Nature Genetics
- what you actually need is a judgment about breadth and consequence, not database status
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Practical verdict
Yes, Nature Genetics is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage from volume 1, issue 1 in April 1992.
If your question is whether a published paper will be visible across the biomedical search workflow, the answer is yes. If your real question is whether the manuscript deserves a Nature Genetics audience rather than a narrower genetics or disease venue, that is a separate editorial-fit call. A Nature Genetics submission readiness check is the best next step if you want that answer before submission.
Frequently asked questions
Yes. Nature Genetics is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.
Yes. The NLM Catalog shows PubMed and MEDLINE coverage from volume 1, issue 1 in April 1992.
Because genetics papers often need to reach genomics, rare-disease, statistical-genetics, and medically adjacent readers through one biomedical search workflow.
Open the NLM Catalog record, confirm the PubMed and MEDLINE coverage lines plus current indexing status, then run a direct PubMed journal search for recent Nature Genetics articles.
Sources
- 1. Nature Genetics NLM Catalog record, NLM.
- 2. NLM Catalog help: current indexing status, NLM.
- 3. Nature Genetics journal homepage, Springer Nature.
- 4. Nature Genetics for authors, Springer Nature.
- 5. Nature Genetics in PubMed, PubMed.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Nature Genetics Submission Guide: What Editors Want, What Gets Rejected, and How to Prepare the Package
- How to Avoid Desk Rejection at Nature Genetics
- Is Nature Genetics a Good Journal? Impact Factor, Scope, and Fit Guide
- Nature Genetics Review Time: What Authors Can Actually Expect
- Nature Genetics vs Genome Biology
- Pre-Submission Review for Genetics and Genomics Papers: What Nature Genetics Reviewers Expect
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.